secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2023-12-07T23:59:59+00:00
Accession:  0000012208-23-000074
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad EVP & President of Clinical Diagnostics Group to resign effective Jan 12, 2024
--------------------------------------------------------------------------------

- Dara Grantham Wright notified resignation to pursue another opportunity, effective Jan 12, 2024.
- Wright served as EVP, President of Clinical Diagnostics Group and was a named executive officer.
- Company has initiated a search for her replacement; no successor named yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220823000074/0000012208-23-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220823000074/bio-20231204.htm
  HTML page:      https://secwatch.observer/filing/0000012208-23-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer